These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2809279)

  • 1. High levels of circulating neutralizing antibody in normal animals to recombinant mouse interferon-beta produced in yeast.
    Sedmak JJ; Grossberg SE
    J Interferon Res; 1989 Sep; 9 Suppl 1():S61-5. PubMed ID: 2809279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN; Grossberg SE
    J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neutralizing antibodies in patients treated with recombinant interferon-beta ser.
    Larocca AP; Leung SC; Marcus SG; Colby CB; Borden EC
    J Interferon Res; 1989 Sep; 9 Suppl 1():S51-60. PubMed ID: 2809278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural antibodies to interferon-alpha and interferon-beta are a common feature of inbred mouse strains.
    De Maeyer-Guignard J; De Maeyer E
    J Immunol; 1986 Mar; 136(5):1708-11. PubMed ID: 3950401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
    Reis LF; Le JM; Hirano T; Kishimoto T; Vilcek J
    J Immunol; 1988 Mar; 140(5):1566-70. PubMed ID: 3279118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.
    Fleischmann WR; Fleischmann CM; Gindhart TD
    Cancer Res; 1986 Jan; 46(1):8-13. PubMed ID: 2998611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and incidence of neutralizing antibodies to interferon-alpha-n1.
    Weck PK; Leventhal BG; Brand C; Finter NB
    J Interferon Res; 1989 Sep; 9 Suppl 1():S37-43. PubMed ID: 2553830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of antibodies to interferon-beta in patients treated with recombinant human interferon-beta 1a from mammalian cells.
    Abdul-Ahad AK; Galazka AR; Revel M; Biffoni M; Borden EC
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):27-32. PubMed ID: 9287241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of murine interferon-alpha 12 (MuIFN-alpha12): biological activities and gene expression.
    Tsang SL; Leung PC; Leung KK; Yau WL; Hardy MP; Mak NK; Leung KN; Fung MC
    Cytokine; 2007 Feb; 37(2):138-49. PubMed ID: 17451966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High concentration of recombinant murine interferon-beta enhances the growth of Orientia (formerly Rickettsia) tsutsugamushi Gilliam in mouse L929 cells.
    Tasneen R; Yoshiie K; Ohkawa T; Oda H
    Acta Virol; 1997 Apr; 41(2):77-82. PubMed ID: 9219637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody to human beta interferon: characterization and application.
    Sugi M; Kato H; Fujimoto M; Utsumi J; Hosoi K; Shimizu H; Kobayashi S
    Hybridoma; 1987 Jun; 6(3):313-20. PubMed ID: 3596615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of sera obtained by hyperimmunizing rabbits with interferon from mouse L cells.
    Kisielow B; Inglot AD; Chudzio T
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):37-44. PubMed ID: 444043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of recombinant unmodified and phosphorylatable murine IFN-alpha1 in the methylotropic yeast Pichia pastoris.
    Trajanovska S; Owczarek CM; Stanton PG; Hertzog PJ
    J Interferon Cytokine Res; 2003 Jul; 23(7):351-8. PubMed ID: 14511461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies.
    Kawade Y; Watanabe Y
    Immunology; 1985 Nov; 56(3):489-95. PubMed ID: 4077097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent activation of mouse macrophages by recombinant interferon-gamma.
    Varesio L; Blasi E; Thurman GB; Talmadge JE; Wiltrout RH; Herberman RB
    Cancer Res; 1984 Oct; 44(10):4465-9. PubMed ID: 6432314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors.
    Simon MM; Hochgeschwender U; Brugger U; Landolfo S
    J Immunol; 1986 Apr; 136(8):2755-62. PubMed ID: 3082972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.
    Oberg K; Alm GV
    J Interferon Res; 1989 Sep; 9 Suppl 1():S45-9. PubMed ID: 2809277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.